Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.

@article{Siravegna2016BloodCT,
  title={Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.},
  author={Giulia Siravegna and Alberto Bardelli},
  journal={Molecular oncology},
  year={2016},
  volume={10 3},
  pages={
          475-80
        }
}
Most solid tumors, including colorectal cancers, shed cell-free DNA (ctDNA) in the blood. ctDNA can be analyzed to generate molecular profiles which capture the heterogeneity of the disease more comprehensively then tumor tissue biopsies. This approach commonly called 'liquid biopsy' can be applied to monitor response to therapy, to assess minimal residual disease and to uncover the emergence of drug resistance. This review will discuss current and future developments of ctDNA analysis in the… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

Circulating Tumor DNA as Biomarkers for Cancer Detection

  • Genomics, Proteomics & Bioinformatics
  • 2017
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Aktuelles zur Liquid Biopsy

VIEW 1 EXCERPT
CITES BACKGROUND